Diametric Capital »

Relmada Therapeutics shares owned by Diametric Capital

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $167k 24k 6.96

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Marshall Wace
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management

View all funds holding Relmada Therapeutics